Published in J Anat on September 01, 2005
Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med (2012) 2.36
The role of the purinergic P2X7 receptor in inflammation. J Inflamm (Lond) (2007) 1.50
Leukocyte recruitment and ischemic brain injury. Neuromolecular Med (2009) 1.47
Interleukin-1beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity. J Biol Chem (2008) 1.29
Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J Neuroinflammation (2006) 1.20
Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4? J Neurochem (2010) 1.18
Inflammatory process in Alzheimer's Disease. Front Integr Neurosci (2013) 1.10
Direct conversion of fibroblasts into functional astrocytes by defined transcription factors. Stem Cell Reports (2014) 0.99
A common carcinogen benzo[a]pyrene causes neuronal death in mouse via microglial activation. PLoS One (2010) 0.96
Risk of meningioma and common variation in genes related to innate immunity. Cancer Epidemiol Biomarkers Prev (2010) 0.94
Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences. Neurobiol Learn Mem (2014) 0.91
NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes. PLoS One (2015) 0.90
Three Promoters Regulate Tissue- and Cell Type-specific Expression of Murine Interleukin-1 Receptor Type I. J Biol Chem (2009) 0.88
Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade. J Med Virol (2010) 0.87
New advances on glial activation in health and disease. World J Virol (2015) 0.87
Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria. PLoS One (2013) 0.84
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes. Front Neurosci (2015) 0.84
Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells. J Neuroinflammation (2012) 0.84
Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice. Curr HIV Res (2015) 0.83
Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression. J Biol Chem (2014) 0.81
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders. Front Microbiol (2015) 0.80
The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice. Eur J Pharmacol (2015) 0.80
HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads. Front Microbiol (2015) 0.80
Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection. J Clin Invest (2017) 0.77
Interactions of early adversity with stress-related gene polymorphisms impact regional brain structure in females. Brain Struct Funct (2015) 0.76
Proteomic strategies in multiple sclerosis and its animal models. Proteomics Clin Appl (2007) 0.76
Inflammation in epileptogenesis after traumatic brain injury. J Neuroinflammation (2017) 0.75
The Cox-2 Inhibitor Meloxicam Ameliorates Neuroinflammation and Depressive Behavior in Adult Mice after Splenectomy. J Neurophysiol Neurol Disord (2016) 0.75
Caspase-1 inhibition attenuates activation of BV2 microglia induced by LPS-treated RAW264.7 macrophages. J Biomed Res (2016) 0.75
Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats. Sci Rep (2017) 0.75
A Putative Blood-Based Biomarker for Autism Spectrum Disorder-Associated Ileocolitis. Sci Rep (2016) 0.75
High salt-induced activation and expression of inflammatory cytokines in cultured astrocytes. Cell Cycle (2017) 0.75
I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science (1988) 16.40
Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science (1995) 11.16
Interleukin-1 and interleukin-1 antagonism. Blood (1991) 7.67
NF-kappa B: a lesson in family values. Cell (1995) 7.33
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature (1992) 7.20
Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol (1993) 6.79
Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature (1993) 6.75
Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J (1995) 5.24
Endothelial-leukocyte adhesion molecules. Annu Rev Immunol (1993) 4.96
Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science (1995) 4.85
Signal transduction through NF-kappa B. Immunol Today (1998) 4.54
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology (1996) 4.42
Immune function of astrocytes. Glia (2001) 4.05
A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J (1994) 4.04
NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci (1992) 3.81
Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science (1983) 2.91
The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol (1995) 2.57
Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol (2000) 2.37
Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J Exp Med (1990) 2.33
Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci (2000) 2.27
Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry (2003) 2.04
Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol (2000) 1.99
Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. J Immunol (1986) 1.87
Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model. Mol Cell Biol (1993) 1.54
Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol (1999) 1.39
Annual review prize lecture cytokines - killers in the brain? J Physiol (1999) 1.31
Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am J Pathol (2004) 1.31
Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J Immunol (1995) 1.14
Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology (1995) 1.12
Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1. Modulation by antioxidants. J Immunol (1994) 1.07
Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. J Immunol (2000) 1.06
Loss of Ikappa B-beta is associated with prolonged NF-kappa B activity in human glial cells. J Biol Chem (2000) 1.01
T cells in multiple sclerosis and inflammatory central nervous system diseases. Immunol Rev (1987) 0.99
Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes. J Neuroimmunol (1994) 0.91
Adhesion to human neurons and astrocytes of monocytes: the role of interaction of CR3 and ICAM-1 and modulation by cytokines. J Neuroimmunol (1995) 0.86
Antiinflammatory effects of glucocorticoids in brain cells, independent of NF-kappa B. J Immunol (1999) 0.85